Search for: "Pharma, Inc"
Results 1 - 20
of 1,852
Sort by Relevance
|
Sort by Date
8 Apr 2024, 9:47 am
USA, Inc., No. 2022-1258 (Fed. [read post]
20 Mar 2024, 4:00 am
One such company is Zoetis Inc., an American company that produces medicine and vaccines for pets and livestock. [read post]
19 Mar 2024, 8:42 pm
The Trump defendants’ solvency also means that there’s no Purdue Pharma issue about non-debtors trying to piggyback on the debtor's discharge in exchange for a plan contribution. [read post]
17 Mar 2024, 7:14 pm
Stifel Nicolaus & Co Inc. [read post]
13 Mar 2024, 7:17 am
The recent case of Purdue Pharma v. [read post]
27 Feb 2024, 10:00 pm
The US Court of Appeals for the Federal Circuit in Purdue Pharma L.P. v. [read post]
27 Feb 2024, 10:00 pm
The US Court of Appeals for the Federal Circuit in Purdue Pharma L.P. v. [read post]
27 Feb 2024, 10:00 pm
The US Court of Appeals for the Federal Circuit in Purdue Pharma L.P. v. [read post]
27 Feb 2024, 10:00 pm
The US Court of Appeals for the Federal Circuit in Purdue Pharma L.P. v. [read post]
27 Feb 2024, 10:00 pm
The US Court of Appeals for the Federal Circuit in Purdue Pharma L.P. v. [read post]
27 Feb 2024, 10:00 pm
The US Court of Appeals for the Federal Circuit in Purdue Pharma L.P. v. [read post]
25 Jan 2024, 8:25 pm
(holding that claim construction was a matter of law to be reviewed de novo by the Federal Circuit; but see Teva Pharma. [read post]
19 Jan 2024, 4:00 am
However, in the NCS Multistage Inc. v. [read post]
14 Jan 2024, 9:29 pm
Cir. 2023)Purdue Pharma L.P. v. [read post]
7 Jan 2024, 9:59 pm
SweeGen, Inc. [read post]
3 Jan 2024, 12:01 pm
Rockville-based AbelZeta Pharma Inc. announced the formation of a scientific advisory board for the treatment of inflammatory and immunological diseases. [read post]
27 Dec 2023, 9:59 am
An update on AbelZeta Pharma Inc., which is headquartered in the U.S. in Rockville, will be presented at the J.P. [read post]
21 Dec 2023, 9:34 am
In Purdue Pharma L.P. v. [read post]
14 Dec 2023, 2:38 pm
., Inc. v. [read post]
11 Dec 2023, 5:05 am
Companies across the pharmaceutical landscape are adapting to this new environment, including Amgen Inc., whose $43 billion takeover of Seagen Inc. faces a rigorous FTC review. [read post]